All coccidioidomycosis articles
-
NewsNovel antifungal drug shows promise in some patients with Valley Fever
A study found that olorofim, a first-in-class orotomide antifungal agent, showed efficacy in patients with disseminated coccidioidomycosis (DCM), a rare complication of Valley Fever where the fungus spreads from the lungs to other parts of the body.
-
NewsStudies point to new way to fight potentially deadly Valley Fever
To better understand why Valley Fever spreads in some individuals, researchers found that patients with severe illness had an abnormal immune response. In some cases, the immune system was overactive; in other cases it was underactive.
-
NewsSignificant rise in valley fever cases in El Paso linked to extreme weather and dust
A new study has identified a significant rise in Valley fever cases in El Paso over the past decade and found strong connections between the disease and extreme weather, wind and airborne dust.
-
NewsDogs could help predict valley fever spread in humans
Valley fever, or coccidioidomycosis, is caused by a fungus that thrives in moist soils and becomes airborne during drought. In a new study, researchers show that dogs, who are also susceptible to the disease, can help us understand its spread.
-
NewsValley fever expert shares ‘state-of-the-art’ knowledge about fungal disease
A new review paper focuses on how fungal diseases present in people with healthy immune systems and examines current diagnostics and treatments.